Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options

The epidemiological burden of liver steatosis associated with metabolic diseases is continuously growing worldwide and in all age classes. This condition generates possible progression of liver damage (i.e., inflammation, fibrosis, cirrhosis, hepatocellular carcinoma) but also independently increase...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of molecular sciences 2024-06, Vol.25 (11), p.5640
Hauptverfasser:	Portincasa, Piero, Khalil, Mohamad, Mahdi, Laura, Perniola, Valeria, Idone, Valeria, Graziani, Annarita, Baffy, Gyorgy, Di Ciaula, Agostino
Format:	Artikel
Sprache:	eng
Schlagworte:	Alcohol Animals Atherosclerosis Classification Epidemiology Fatty Liver - complications Fatty Liver - etiology Fatty Liver - metabolism Fatty Liver - therapy Genes Health aspects Health care access Humans Hypoglycemic agents Inflammation Liver cancer Liver cirrhosis Liver diseases Metabolic Diseases - etiology Metabolic Diseases - metabolism Metabolism Mortality Non-alcoholic Fatty Liver Disease - complications Non-alcoholic Fatty Liver Disease - drug therapy Non-alcoholic Fatty Liver Disease - etiology Non-alcoholic Fatty Liver Disease - metabolism Non-alcoholic Fatty Liver Disease - therapy Obesity Overweight Pathogenesis Review Stigma Type 2 diabetes Ultrasonic imaging
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!